Targeted next-generation sequencing will make it possible to study the spectrum of FBN1 gene mutations efficiently and comprehensively, providing reference points for early screening and genetic counseling of acromelic dysplasia (17). The gene discussed is FBN1; the disease is acromelic dysplasia.